|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jul 22, 2022 04:35PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Dec 11, 2019 09:42PM
|
|
Re: The latest numbers for Alberta.
|
2
|
Resverlogix Corp.
|
Sep 14, 2021 11:58PM
|
|
Re: Safety and Efficacy
|
2
|
Resverlogix Corp.
|
Mar 03, 2017 12:03AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 23, 2020 02:22AM
|
|
Re: Anyways Gran Oso.....
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 11:06PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 15, 2022 12:21PM
|
|
Re: Thoughts on ZCC
|
2
|
Zenith Epigenetics
|
Sep 05, 2021 05:42PM
|
|
Re: Response from Sarah -were still a go
|
2
|
Resverlogix Corp.
|
Dec 02, 2021 04:54PM
|
|
Re: All quiet on the western front
|
2
|
Resverlogix Corp.
|
Jan 03, 2020 01:23PM
|
|
Re: TNBC no longer active?
|
2
|
Zenith Epigenetics
|
Jun 28, 2023 12:10AM
|
|
Re: Wow! Quite the read!
|
2
|
Resverlogix Corp.
|
May 29, 2021 09:03PM
|
|
Re: Excerpt of a recent Bloomberg article......
|
2
|
Resverlogix Corp.
|
Jan 15, 2020 05:58PM
|
|
Re: As Pfizer charges ahead....
|
2
|
Resverlogix Corp.
|
Sep 05, 2021 06:10PM
|
|
Re: Price of ROFR for USA
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 08:10AM
|
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 12:00PM
|
|
Re: TMX closed due to technical issues....
|
2
|
Resverlogix Corp.
|
Apr 30, 2018 06:37AM
|
|
Re: How common is this infectious pathway, or whatever the correct term is?
|
2
|
Resverlogix Corp.
|
Jan 04, 2021 01:30PM
|
|
Re: Funny how,...
|
2
|
Resverlogix Corp.
|
Dec 24, 2019 12:11PM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 23, 2018 11:27PM
|
